Clinical Trial Update: Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin [Phase 4]

View source ↗

Summary

This update covers a Phase 4 trial of vildagliptin 50 mg twice daily in patients with type 2 diabetes mellitus inadequately controlled with metformin. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED